← All diseases

Hormone and bone diseases

X-linked hypophosphatemia (XLH)

An inherited phosphate disease. The kidneys lose too much phosphate in the urine. Phosphate in the blood falls, the bones become soft and the legs may bow.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Hormone and bone diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

A change in the PHEX gene leads to an increase in a protein called FGF23. This protein reduces how much phosphate the kidneys take back and how much the gut absorbs. Phosphate is needed for bones and teeth. When phosphate is low, children get rickets and adults get softening of the bones.

Which symptoms can occur?

Symptoms can be very different even within the same family. Some people only have low blood phosphate.

  • Slow growth and short stature in childhood
  • Bowed legs
  • Bone and joint pain
  • Dental abscesses, meaning a build-up of infection in a tooth
  • Painful stress fractures in adults
  • Calcium deposits where tendons and ligaments attach to bone
  • Early fusion of the skull bones or hearing loss

How is it diagnosed?

Bowed legs and short stature are examined with X-rays. In the blood, phosphate is low while calcium and vitamin D are normal. The phosphate loss through the kidneys is measured. A genetic test shows the exact cause.

Treatment and care

There is an approved treatment specific to the disease. This treatment blocks the effect of FGF23 and can be used in both children and adults. The older approach is phosphate and active vitamin D supplements. These supplements need regular blood and urine checks. Dental care, orthopedic follow-up and surgery if needed are provided. Early treatment can reduce bone problems. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through the X chromosome. Girls and boys can be affected in a similar way. An affected mother passes it to each child with a 50 percent chance. An affected father passes it to all his daughters but not to his sons. Genetic counselling guides the family.

Source: MedlinePlus Genetics: X-linked hypophosphatemia · NORD: Familial Hypophosphatemia

Key facts

How common is it?
New cases per year: 1-9 per 100 000 (Worldwide) · Prevalence: 1-9 per 100 000 (Worldwide)
How is it inherited?
X-linked dominant
When does it usually start?
Childhood, Infancy
Gene(s) involved
PHEX

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about XLH

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 3 active interventional studies for this disease. 3 are recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Hormone and bone diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:89936

No separate ICD-11 code; WHO classifies this disease under: 5C63.22

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.